SEVEN LIFESTYLE FACTORS DRIVING EXPLOSION IN BREAST CANCER DIAGNOSES, GLOBAL STUDY REVEALS

Seven everyday lifestyle factors are fueling a global surge in breast cancer, experts warn – with cases set to rise by a third worldwide despite major advances in treatment and screening.

A major international analysis has found breast cancer diagnoses are on track to climb from 2.3 million a year to 3.5 million by 2050, while annual deaths from the disease are projected to jump 44 percent, to almost 1.4 million.

Researchers say more than a quarter of the healthy years lost to breast cancer globally can now be traced to seven modifiable risk factors: obesity, high blood sugar, smoking, secondhand smoke, heavy alcohol use, low physical activity and high red meat intake.

The findings come from the Global Burden of Disease Study Breast Cancer Collaborators, published in The Lancet Oncology, which analyzed data from 204 countries collected over more than three decades.

Despite breakthroughs ranging from targeted therapies to experimental vaccines, the study concludes breast cancer remains the leading cause of cancer-related illness and premature death among women worldwide, with lifestyle and demographic changes increasingly driving the disease.

Researchers examined trends between 1990 and 2023 and modelled future patterns through to 2050, dividing countries into 21 regions based on geography, income and disease risk. 

According to the analysis, in the US, annual breast cancer cases rose by 23.4 percent between 1990 and 2023, reaching approximately 259,000 diagnoses a year.

The US now has an age-standardized incidence rate of 92.5 per 100,000 women, one of the highest in the world and slightly above the UK's rate.

In the UK, breast cancer cases have risen sharply over the past three decades. The study shows that annual new diagnoses increased by 24.6 percent between 1990 and 2023, reaching around 54,800 cases a year.

Britain now records an age-standardized incidence rate of 89.5 cases per 100,000 women, placing it among the highest-incidence countries globally, alongside other high-income Western European nations and the US.

Despite this rise in diagnoses, outcomes have improved markedly. 

While 15,500 women died from breast cancer in 2023, the age-standardized death rate has fallen by 43 percent since 1990, reflecting earlier detection and more effective treatment, even as absolute case numbers continue to grow.

As in Britain, rising diagnoses in the US have been accompanied by major improvements in survival. Although 52,200 American women died from the disease in 2023, the age-standardized breast cancer death rate has fallen by 40.8 percent since 1990.

This divergence, rising incidence but falling death rates, places both the UK and US firmly among high-income countries where screening and treatment have transformed outcomes, even as lifestyle risks and aging populations drive more diagnoses.

The picture is far bleaker in many low- and middle-income countries, where cases are rising rapidly but health systems are struggling to cope.

In regions such as sub-Saharan Africa and South Asia, incidence rates remain lower, around 44 cases per 100,000 women, yet breast cancer deaths surged by nearly 99 percent between 1990 and 2023, driven by later diagnosis and limited access to care.

Experts say high-income countries typically benefit from widespread screening and comprehensive treatment, while in poorer nations women are far more likely to be diagnosed at advanced stages, when survival prospects are much worse.

The burden is also increasingly falling on younger women. While three times as many new cases still occur in women over 55, the study found rates among premenopausal women are rising faster.

Between 2004 and 2021, breast cancer cases in women ages 20 to 39 increased by nearly three percent – more than double the rise seen in women in their 70s. 

The drivers remain unclear, but experts believe lifestyle factors are playing an increasingly important role.

Overall, the researchers linked 28 percent of global breast cancer disability-adjusted life years, a measure of healthy years lost, to the seven modifiable risks.

In high-income countries such as the UK and US, obesity emerged as the single largest contributor, particularly among postmenopausal women.

Weight gain is common after menopause as metabolism slows, and excess fat tissue becomes the body's main source of estrogen once the ovaries stop producing it.

Higher estrogen levels are known to stimulate the growth of hormone-sensitive breast tumors, while obesity is also linked to chronic inflammation and insulin resistance, both of which may promote cancer development. 

Alcohol, smoking and physical inactivity also played significant roles. Alcohol is thought to raise breast cancer risk by increasing estrogen levels and damaging DNA in breast cells, while smoking exposes tissue to carcinogenic compounds that can trigger genetic mutations.

Low physical activity is linked to weight gain, higher insulin levels and poorer immune surveillance against emerging cancer cells.

Red meat was the smallest contributor overall, but researchers note growing evidence linking it to breast cancer risk – particularly when consumed in adolescence or early adulthood. High levels of heme iron and carcinogenic compounds formed during high-temperature cooking are thought to damage DNA.

Dr Marie Ng, a senior author of the study, said the findings point to a major opportunity for prevention. 'With more than a quarter of the global breast cancer burden linked to modifiable lifestyle factors, there is real potential to alter the trajectory for the next generation,' she said.

Researchers stress that medical advances remain vital – but warn that without urgent action on lifestyle risks, breast cancer cases will continue to rise worldwide.

Read more

2026-03-02T23:47:17Z